Viewing Study NCT00845104

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:19 PM

Ignite Modification Date: 2025-12-29 @ 8:55 PM

Study NCT ID: NCT00845104

Status: WITHDRAWN

Last Update Posted: 2015-03-06

First Post: 2009-02-17

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Sponsor: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module